Reich K, Blauvelt A, Lebwohl M, Papp K, Rich P, Strober B, De Cuyper D, Madden C, Peterson L, Vanvoorden V, Warren R. Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 4];5(1):s21. Available from: https://jofskin.org/33014/index.php/skin/article/view/1174